Has Covid become less dangerous than flu?
New figures suggest Covid-19 poses lower death risk but experts warn against complacency
The vast majority of people infected with Covid-19 in England now have a marginally lower risk of dying than people who catch seasonal flu, an analysis of official data has found.
The Financial Times reported that owing to “a combination of high levels of immunity and the reduced severity of the Omicron variant”, the proportion of Covid-19 infections that result in death has dipped to 35 per 100,000 cases.
By contrast, the equivalent number of flu cases would result in about 40 deaths, according to calculations by the paper’s chief data reporter John Burn-Murdoch and health reporter Oliver Barnes.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
At the peak of last winter’s Alpha wave, before the UK’s mass vaccination programme had begun, Covid-19 was killing more than 1,000 of every 100,000 infected Britons.
“Is Omicron the same as flu? No. But the vaccines have made the risks to the individual very similar,” said Dr Raghib Ali, senior clinical research associate in epidemiology at Cambridge University. So a “large spike” in hospital admissions or deaths was “unlikely” while Omicron remained the dominant strain, he added.
A separate analysis of government figures by the Daily Mail put the Covid-19 infection fatality rate at around 0.03%. The rate for seasonal flu was between 0.01% and 0.05%, suggesting that for the first time in the pandemic, “the two viruses now pose a similar threat”, the paper reported.
The transmissibility factor
Despite the drop in the Covid infection fatality rate, experts are calling for caution.
Omicron’s rapid transmissibility meant “the threat of Covid could still not be equated to flu”, Christina Pagel, professor of operational research at University College London and a member of the Independent Sage group of scientific experts, told the FT.
The paper’s Burn-Murdoch agreed that while Covid-19 had become less lethal on a per-infection basis, the “sheer volume” of infections meant the risk of death over the winter from respiratory illness has “remained elevated”. These deaths were about 50% higher than over a “typical” flu season, demonstrating that the virus was still significantly adding to the winter disease burden, he said in a Twitter thread.
Professor Paul Hunter, an infectious diseases expert from the University of East Anglia, told the Daily Mail that there also “remains uncertainty about the impact of future variants”.
As Nature magazine noted last month, “there is no guarantee that the next dominant variant will sprout from the ‘mild’ Omicron branch of the Sars-CoV-2 family tree”.
And as the Mail pointed out, real time infection-fatality rates “can vary drastically” in countries across the world “based on previous immunity, prevalence of obesity and other medical conditions, and the population age structure”.
Professor Julian Hiscox, chair of infection and global health at Liverpool University, also cautioned against “complacency”, and called for the UK’s spring booster jab programme to be widened from just over-75s and immunosuppressed people to all over-50s.
“We want to avoid dithering with the extra booster now and then getting caught on the back foot,” Hiscox told the FT.
“All of this could be academic if a new variant comes along,” he warned.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
Will the murder of a health insurance CEO cause an industry reckoning?
Today's Big Question UnitedHealthcare CEO Brian Thompson was shot and killed in what police believe was a targeted attack
By Justin Klawans, The Week US Published
-
What are Trump's plans for public health?
Today's Big Question From abortion access to vaccine mandates
By Devika Rao, The Week US Published
-
What went wrong at CVS?
Today's Big Question Pharmacy chains are in crisis
By Joel Mathis, The Week US Published
-
Long Covid: study shows damage to brain's 'control centre'
The Explainer Research could help scientists understand long-term effects of Covid-19 as well as conditions such as MS and dementia
By The Week UK Published
-
FDA OKs new Covid vaccine, available soon
Speed read The CDC recommends the new booster to combat the widely-circulating KP.2 strain
By Peter Weber, The Week US Published
-
Mpox: how dangerous is new health emergency?
Today's Big Question Spread of potentially deadly sub-variant more like early days of HIV than Covid, say scientists
By The Week UK Published
-
What is POTS and why is it more common now?
The explainer The condition affecting young women
By Devika Rao, The Week US Last updated
-
Brexit, Matt Hancock and black swans: five takeaways from Covid inquiry report
The Explainer UK was 'unprepared' for pandemic and government 'failed' citizens with flawed response, says damning report
By Harriet Marsden, The Week UK Published